NCT06233695View on ClinicalTrials.gov

Gender-based Differences in the Outcome of Treatment With Aldosterone Antagonists in Patients With Heart Failure

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

October 15, 2022

Primary Completion Date

July 15, 2023

Study Completion Date

December 1, 2023

Conditions
Heart FailureHeart Failure With Reduced Ejection FractionHeart Failure NYHA Class IIHeart Failure NYHA Class IIIHeart Failure NYHA Class IV
Interventions
DRUG

Potassium sparing diuretic

Starting Spironolactone or Eplerenone at the time of enrollment.

Trial Locations (1)

Unknown

Faculty of Medicine, Alexandria University Hospitals, Alexandria

All Listed Sponsors
lead

Alexandria University

OTHER